Neuberger Berman Group’s 10x Genomics TXG Stock Holding History

Neuberger Berman Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$491K	Buy	12,798 +473	+4%	+$12.4K	﹤0.01%	1806
2026 Q1	$262K	Buy	12,325 +852	+7%	+$17K	﹤0.01%	1896
2025 Q4	$187K	Sell	11,473 -107	-0.9%	-$1.62K	﹤0.01%	1970
2025 Q3	$135K	Buy	+11,580	New	+$151K	﹤0.01%	1949
2024 Q2	–	Sell	-8,884	Closed	-$333K	–	1972
2024 Q1	$333K	Sell	8,884 -8,028	-47%	-$353K	﹤0.01%	1611
2023 Q4	$946K	Buy	+16,912	New	+$736K	﹤0.01%	1507
2023 Q3	–	Sell	-4,807	Closed	-$268K	–	1881
2023 Q2	$268K	Buy	+4,807	New	+$260K	﹤0.01%	1628

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group's TXG Position: Q2 2026 in Review

Neuberger Berman Group increased its 10x Genomics (TXG) stake by 3.8% in Q2 2026, buying an estimated $12.4K and bringing the position to 12,798 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

Neuberger Berman Group first reported a position in TXG in Q2 2023 and has held it in 7 quarters since. The position peaked at $946K in Q4 2023. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Neuberger Berman Group held 12,798 shares of 10x Genomics worth $491K as of Q2 2026.
Neuberger Berman Group bought 473 10x Genomics shares in Q2 2026, an estimated $12.4K.
10x Genomics made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1806 holding.
Neuberger Berman Group first reported a position in 10x Genomics in Q2 2023 and has held it in 7 quarters since.
Neuberger Berman Group's 10x Genomics position peaked at $946K in Q4 2023.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.